Recent studies examine the burden of CRSwNP, looking at quality of life in patients and caregivers and assessing how CRSwNP ...

Not only adults, nasal polyps can also occur in children. Polyps are an inflammation of the nasal membranes and sinuses that ...

and mean nasal obstruction verbal response scale score by 0.24 on the 0-3 point scale (95% CI -0.39 to -0.08) in combined findings from the ANCHOR-1 and -2 trials over 52 weeks. The first ...

Results demonstrate that depemokimab significantly improves total nasal polyps score and nasal obstruction symptoms while maintaining a safety profile comparable to placebo. Chronic rhinosinusitis ...

The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...

Total symptom scores, nasal obstruction, and doctor and patient perception of improvement were measured as markers of disease severity. Results: Although not statistically significant, both ...

Phase 3 trials showed significant improvements in nasal polyp size and obstruction. Join Nic Chahine live on Wednesday, March 19, at 6 PM ET for a step-by-step breakdown of how to to capitalize on ...

In the SWIFT and ANCHOR trials, depemokimab demonstrated statistically significant reductions in nasal polyp size, obstruction, and asthma exacerbations compared to placebo. The FDA has accepted GSK’s ...